Effect of Bone-related and Soft-tissue-related Variables on the Marginal Bone Loss of Platform-matched and Platform Switched Dental Implants

Sponsor
University of Salamanca (Other)
Overall Status
Recruiting
CT.gov ID
NCT05670340
Collaborator
(none)
60
1
2
42.7
1.4

Study Details

Study Description

Brief Summary

In this clinical trial the effect of the implant-abutment morphology (platform-switched vs platform matched) will be assessed in both soft tissue (soft tissue thickness) and hard tissue (marginal bone loss) outcomes. Several clinical predictors (initial implant position level, gingival biotype, abutment height and prosthetic emergence profile) will also be taken into account as modulating factors of the clinical outcome.

Condition or Disease Intervention/Treatment Phase
  • Device: Switched Prosthetic Profile
  • Device: Matched Prosthetic Profile
N/A

Detailed Description

This prospective clinical trial is conducted at the Dental Clinic of the Faculty of Medicine of the University of Salamanca. The protocol was developed in accordance with the 1975 Declaration of Helsinki, and later approved by the Bioethics Committee of the University of Salamanca with the number (Ref:473/2020)

Before initiating any procedure, each patient received information about the study design and signed an informed consent. The subjects are recruited consecutively following the admission protocols of the Dental Clinic of the Faculty of Medicine of the University of Salamanca,

Salamanca, Spain. The inclusion criteria are:

(1) Patients of legal age (>18 years); (2) in need of at least one maxillary or mandibular dental implant to be inserted in mature bone (more than 4 months after tooth extraction) in the posterior area (premolars and molars); (3) with good oral hygiene (plaque and gingival index ≤ 25%). The exclusion criteria included clinical conditions that contraindicated implant surgery, (1) patients with immunological alterations, pregnant and lactating, (2) heavy smokers > 20 cigarettes/day, (3) with the need for bone or soft tissue augmentations, (4) patients whose anatomy prevented the correct three-dimensional placement of the implant to perform prosthetically guided screwed restorations.

All implants were placed by an experienced implantologist following standard procedures and the manufacturer's recommendations. All implants were connected to a transmucosal abutment to heal in one-stage approach. Several variables were collected in this surgical phase (bone quality, implant stability, implant-bone level, mucosal thickness, keratinized mucosa width ...)

After 3 to 4 months of implant healing all the clinical parameters were reevaluated and the final impression will be used for the manufacturing of a porcelain-fused to metal screwed crowns.

Two types of data will be analyzed: Cross-sectional and longitudinal data. On the one hand, cross-sectional data included sociodemographic (sex and age), behavioral (smoking, oral hygiene..) clinical (antagonist, adjacent dentition, arch location, implant diameter and length, insertion torque values, bone density, implant-level...) and prosthetics (abutment and prosthetic profiles, interocclusal prosthetic space, cantilever lengths...).

On the other hand, the longitudinal variables were classified into 2 types, related to the gingival tissues and related to the surrounding bone. Regarding the gingival tissues these were the longitudinal variables assessed in different follow-up observations (at 3, 6 and 12 months): plaque and gingival index, keratinized mucosa width. Regarding the bone-related variables the implant stability by ISQ as well as the marginal bone position were also measured at 3, 6 and 12 months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
only the care provider knows the group asignement
Primary Purpose:
Treatment
Official Title:
Effect of Bone-related and Soft-tissue-related Variables on the Marginal Bone Loss of Platform-matched and Platform Switched Dental Implants
Actual Study Start Date :
Jun 22, 2020
Anticipated Primary Completion Date :
Feb 20, 2023
Anticipated Study Completion Date :
Jan 12, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Swithed-platform

In this group the implants will be rehabilitated with a narrower emergence profile for the prosthetic rehabilitation.

Device: Switched Prosthetic Profile
The implant will be rehabilitated with a switched emergence profile

Active Comparator: Matched-platform

This the conventional approach in wich the prosthetic rehabilitation is matched with the implant-platform dimensions

Device: Matched Prosthetic Profile
The implant will be rehabilitated with a matched emergence profile

Outcome Measures

Primary Outcome Measures

  1. Change in the Peri-implant Marginal Bone level [At baseline (reference), in comparison with 3, 6 and 12 months]

    The implant-bone level is assesssed radiographicly

  2. Change in the Implant stablity quotient [At baseline (reference), and in comparison with the 3 months follow-up]

    The ISQ is assesssed by Osstell

  3. Change in the Gingival Thickness [At baseline (reference) and in comparison with the 3, 6 and 12 months follow-up]

    The gingival thickness will be assessed by measuring the keratinized region around implants with a periodontal probe and a thickness caliper

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients of legal age (>18 years).

  • With rehabilitation needs with 1 maxillary or mandibular implant in mature bone (more than 4 months after tooth extraction) in the posterior sector (premolars and molars).

  • With good hygiene (plaque and gingival index ≤ 25%).

Exclusion Criteria:
  • Medical conditions that contraindicated implant surgery.

  • Patients with immunological alterations, pregnant and lactating.

  • Heavy smokers > 20 cigarettes/day,

  • Requiring bone augmentations or of soft tissues.

  • Patients whose anatomy prevented the correct three-dimensional placement of the implant to perform prosthetically guided screw-retained restorations.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Javier Montero Salamanca Spain 37007

Sponsors and Collaborators

  • University of Salamanca

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
JAVIER MONTERO, Full Professor in Prosthodontics, University of Salamanca
ClinicalTrials.gov Identifier:
NCT05670340
Other Study ID Numbers:
  • Usal_2020_433
First Posted:
Jan 4, 2023
Last Update Posted:
Jan 4, 2023
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by JAVIER MONTERO, Full Professor in Prosthodontics, University of Salamanca
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 4, 2023